News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
Boehringer Ingelheim Corporation Opens ‘Centre Of Competence’ Opens As Part Of A €100m China Plan
September 2, 2010
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Oustourcing Pharma -- Boehringer Ingelheim has opened its ‘Centre of Competence’ (CoC) in Shanghai to optimise API and chemical intermediates sourcing in China.
Twitter
LinkedIn
Facebook
Email
Print
Real estate
Asia
Boehringer Ingelheim
MORE ON THIS TOPIC
Funding
AI-Focused Fund Breakout Raises $114M To Support Early-Stage Biotechs
March 10, 2026
·
2 min read
·
Tristan Manalac
GLP-1s
Novo Nordisk Agrees To Sell GLP-1 Drugs Via Hims & Hers, Ending Dispute
March 9, 2026
·
2 min read
·
Nick Paul Taylor
Cancer
Ipsen Pulls Cancer Drug Amid Risk of Secondary Malignancies
March 9, 2026
·
2 min read
·
Tristan Manalac
Layoff Tracker
Vertex Terminates 20 in Reorganization Push
March 9, 2026
·
32 min read
·
BioSpace Editorial Staff
